Compounding Pharmacies, Immunity and Immunization

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.

Vaccines

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Flu Vaccines Are a Go

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Trending Sources

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacies Need Strategies to Improve Health Care Access

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Educate Patients About Safe Medication Disposal

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacists Can Provide Travel Health Tips for Patients

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Atrium Health: Pioneering Outpatient Transplant Models Driven by Pharmacist-Led Care

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Correct Patient Misconceptions Around Biosimilars

Large Real-World Study Validates Idecabtagene Vicleucel Outcomes Seen in KarMMa Trial

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

Because Ned Said: New Technology Helps Prevent Opioid Overdose

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Stay Connected